Dr Reddys News
Hyderabad-based pharmaceutical major Dr Reddy’s Laboratories announced it would be acquiring the German firm Nimbus Health — licensed pharmaceutical wholesaler from Germany focusing on medical cannabis
Azerbaijan trial studying effects of combined Sputnik and AstraZeneca vaccines reports positive results
When contacted for their response to the latest development, both Serum Institute of India and Dr Reddy's Laboratories refused to comment at this time.
Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose; expects 36 mn doses in couple of months
Justifying the price, the official said it was done based on its landing price and other expenses involved in bringing it to people. He said the price may come down once local manufacturing starts
The Hyderabad-based pharma company said that the first dose of the vaccine was administered to a beneficiary as part of a 'limited pilot'
Dr Reddy's was the top gainer in the Sensex pack, followed by ONGC, HDFC, IndusInd Bank, ICICI Bank, Sun Pharma and Kotak Bank
A senior executive from Dr Reddy's said the vaccine will be imported in a frozen condition, maintaining a temperature of -18 to -22 degrees Celsius
Never spoke of vaccinating entire country, says Centre; initial findings of Chennai case did not necessitate trial stoppage: ICMR
Meanwhile, Dr Reddy's Laboratories Ltd announced the commencement of adaptive phase 2/3 clinical trials for Russia's COVID-19 vaccine Sputnik V in India
As race to COVID-19 vaccine heats up, a look at major jabs, development and clinical trials underway
According to WHO, there are 48 COVID-19 vaccine candidates are undergoing clinical evaluation, of which eleven are at late-stage trials, whereas, 164 candidate vaccines are in preclinical evaluation
The health minster said that no state will be given preferential treatment and the distribution of vaccines will be equitable.
COVID-19 vaccine to reach 30 cr by July-Aug, says Harsh Vardhan; healthcare workers, people above 65 yrs priority
Stating that everything is being decided by experts with a scientific point of view, the Union health minister expressed confidence that the COVID-19 vaccine will be ready in the next three to four months
First batch of Sputnik V vaccine likely to reach Kanpur medical college for phase 2,3 trials by next week
As many as 180 volunteers have registered for the trials and the ethics committee of the college has also given permission, said college principal RB Kamal
DCGI approves Dr Reddy's request to conduct Phase 2, 3 clinical trials with Russia's Sputnik V COVD-19 vaccine
RDIF will also supply 100 million doses of Dr Reddy's after receiving Indian regulatory approval.
COVID-19 recoveries continue to surpass new cases; next two-and-a-half month period crucial says Harsh Vardhan
The health ministry also said on Friday that India has one of the lowest COVID-19 deaths per million population in the world, with less than 1,000 fatalities registered daily since 4 October,
Dr Reddy's asked to resubmit phase 2,3 trial application for Russia's Sputnik V COVID-19 vaccine by DCGI
Dr Reddy's trials will have to be first assessed in a small group of volunteers to study its efficacy before it can be tested on a larger population.
RDIF, Dr Reddy's Lab tie up for Sputnik V human trials, distribution of 100 mn doses of the COVID-19 vaccine in India
As of 1 August, Phase I and II of the vaccine were complete and by 11 August, Russian President Vladimir Putin had registered it as the world's first vaccine.
The Serum Institute of India, which had paused phase 2 and phase 3 trials of the Oxford University's vaccine, received the go-ahead from the DCGI to resume the trials in India
Coronavirus Updates: Maharashtra reports 14,492 new COVID-19 cases, 326 deaths; tally rises to 6,43,289
Coronavirus LIVE Updates: As many as 26 volunteers who reached the Air-India Express plane crash site in Kozhikode evacuated the injured passengers on 7 August, have tested positive for COVID-19
Govt's unlock Phase 1.0 enthuses markets: Sensex soars 879 points, Nifty jumps to 9,800-level; Bajaj Finance top gainer at around 11%
The Sensex surged driven by gains in Reliance Industries, HDFC twins and TCS as investor optimism heightened after the government began the process of unlocking the economy.
Dr Reddy's Q4 profit jumps 76% to Rs 764 cr on higher sales in US, Europe; revenue up 10% at Rs 4,432 cr
Dr Reddy's said various initiatives have been undertaken to ensure that our manufacturing-related operations continue unabated enabling it to serve the patients.
Dr Reddy's Labs to acquire branded generics business of Wockhardt for Rs 1,850 cr; deal to help scale-up presence in home market
Dr Reddy's will acquire select divisions of its branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives.